US Stock Market Move | Vaccine concept stocks rise and fall differently. Novavax, Inc. (NVAX.US) rose more than 5.4%.

On Friday, vaccine concept stocks fluctuated, with Novavax, Inc. (NVAX.US) rising, reaching a high of over 5.4% to $12.57 per share at the time of writing. The company announced that their updated COVID-19 vaccine has been approved for use in the United States for individuals aged 12 and above. Moderna (MRNA.US) decreased by nearly 4% to $66.92 per share. Moderna plans to launch a skin cancer vaccine based on mRNA as early as next year. It was reported that Moderna has released mid-term data on their individualized cancer vaccine named mRNA-4157, which is being used in combination with Merck & Co., Inc.'s (MRK.US) PD-1 therapy Keytruda for the treatment of melanoma. Pfizer Inc. (PFE.US) also saw a slight decrease of 0.22%.